Dr Themba Ginindza is an experienced Epidemiologist who has conducted research across the diverse disease spectrum, covering STIs (HPV, HIV/AIDS, CT, NG, TV, Syphilis), Sexually Reproductive Health (SRH), and Cancer Epidemiology. He also teaches and supervises epidemiological research at the postgraduate level. Currently, he is the Lead PI in the Multinational Lung Cancer Control Programme (MLCCP) involving Kenya, South Africa, Tanzania, Eswatini, and more recently Lesotho and Ethiopia. He is Co-PI in the Cervical cancer Screening and Treatment algorithms study using HPV testing in Africa (CESTA) in South Africa. He has collaborated on many multidisciplinary projects in South Africa and beyond, including an ongoing HPV vaccine roll-out in Eswatini and Cervical Cancer Elimination research project. He led the Burden of HPV infection and HPV-related conditions among sexually active women in the Kingdom of Eswatini: its implications during the era of HIV epidemic research. He worked on a Clinical Trial on Cervical cancer Screening and Treatment algorithms study using HPV testing in Africa in KZN. Additionally, he developed the South African Rotavirus surveillance system; previously worked in planning, monitoring, and evaluation of HIV/AIDS programs, coordination of HIV/AIDS research projects in Eswatini and South Africa, managing and analyzing hospital mining data for monitoring admissions and out-patients related to Influenza and pneumonia infections. Finally, he has international working experience in countries like Malawi, the Philippines, the Kingdom of Eswatini, and Finland.